title: Pulmonary fibrosis associated with nabumetone.
abstract: A patient is described who developed a rapid onset of pulmonary fibrosis following treatment with a new non-steroidal anti-inflammatory drug, nabumetone. Resolution of symptoms, physical signs and radiographic changes followed drug withdrawal and steroid therapy.
authors.affiliation: Chest Medical Unit, Papworth Hospital, Cambs, UK.
authors.forename: A
authors.initials: A
authors.lastname: Morice
authors.forename: A
authors.initials: A
authors.lastname: Atherton
authors.forename: F
authors.initials: F
authors.lastname: Gleeson
authors.forename: S
authors.initials: S
authors.lastname: Stewart
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002074:Butanones / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D000077430:Nabumetone; D011239:Prednisolone / Q000627:therapeutic use; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D011859:Radiography
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D002074:Butanones; D011239:Prednisolone; D000077430:Nabumetone